Lupus anticoagulant hypoprothrombinemia syndrome associated with systemic lupus erythematosus in children: report of two cases and systematic review of the literature
We report two children with systemic lupus erythematosus (SLE) having severe bleeding manifestations and lupus anticoagulant hypoprothrombinemia syndrome (LAHPS) along with a review of published cases of childhood SLE and LAHPS. We report clinical and laboratory profile of two children diagnosed with childhood SLE and LAHPS. We also conducted literature search to identify similar published cases and a review was performed. An 8-year-old girl had presented with fever, arthralgia, alopecia, anasarca and bleeding from multiple sites. She was diagnosed to have SLE based on laboratory investigations which showed anemia, thrombocytopenia, low complements, positive anti-nuclear antibody (ANA) and double standard DNA (dsDNA) antibodies. She was also found to have prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT), positive lupus anticoagulant (LA) and low factor II levels. She was diagnosed to have SLE with LAHPS and treated with intravenous methylprednisolone, intravenous immunoglobulin and cyclophosphamide with good outcome. Patient 2 was a 7-year-old-boy who was diagnosed to have SLE when he presented with fever, anasarca, malar rash, arthritis and bleeding from skin and mucosa. Laboratory investigations revealed anemia, proteinuria, low complements, positive ANA and anti-dsDNA titre. Coagulation studies showed deranged PT and aPTT, positive LA and low factor II levels. He was diagnosed to have SLE with LAHPS and was treated with intravenous methylprednisolone and oral mycophenolate mofetil. Review of literature of cases with childhood SLE and LAHPS showed that there are 32 cases have been reported till date which have been summarized. LAHPS is an uncommonly identified cause of bleeding in patients with SLE and must be suspected while evaluating these children.
KeywordsChild Systemic lupus erythematosus Factor II deficiency Hypoprothrombinemia Lupus anticoagulant hypoprothrombinemia syndrome
RKP: writing of initial draft of manuscript, editing and revision of manuscript at all stages of its production, review of literature and management of patients. AKJ/AS/PS/SG: contributed to editing of manuscript, review of literature and management of patients. NK/AR/JA/SS: critically revised the manuscript, review of literature and management of patients. DS: critically revised the manuscript at all stages of its production, final approval of manuscript, review of literature and management of patients.
Compliance with ethical standards
Conflict of interest
All authors declare no conflict of interest.
The study complies with the Declaration of Helsinki. The study was approved by Department Review Board (DRB), Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
An informed consent was obtained from parents of the patients for publication.
- 9.das Chagas Medeiros MM, Bezerra MC, Braga FNHF, da Justa Feijão MRM, Gois ACR, do Rebouças VC, de Carvalho R, Carvalho TMAZ, Ribeiro LNS ÁM (2016) Clinical and immunological aspects and outcome of a Brazilian cohort of 414 patients with systemic lupus erythematosus (SLE): comparison between childhood-onset, adult-onset, and late-onset SLE. Lupus 25:355–363CrossRefPubMedGoogle Scholar
- 21.Biggs R, Denson KWE The mode of action of a coagulation inhibitor in the blood of two patients with disseminated lupus erythematosus (DLE). Br J Haematol 10:198–216Google Scholar
- 30.Favier R, Kheyar T, Renolleau S, Tabone MD, Favier M, Ulinski T (2012) Lupus anticoagulant-hypoprothrombinemia syndrome revealing systemic lupus in an 11-year old girl in a context of clinical and biological emergency. Ann Biol Clin (Paris) 70:226–230Google Scholar